BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18418215)

  • 1. Nordihydroguaiaretic acid restores expression of silenced E-cadherin gene in human breast cancer cell lines and xenografts.
    Cui Y; Lu C; Kang A; Liu L; Tan S; Sun D; Hu J; Ma X
    Anticancer Drugs; 2008 Jun; 19(5):487-94. PubMed ID: 18418215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest.
    Cui Y; Lu C; Liu L; Sun D; Yao N; Tan S; Bai S; Ma X
    Life Sci; 2008 Jan; 82(5-6):247-55. PubMed ID: 18164318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
    Youngren JF; Gable K; Penaranda C; Maddux BA; Zavodovskaya M; Lobo M; Campbell M; Kerner J; Goldfine ID
    Breast Cancer Res Treat; 2005 Nov; 94(1):37-46. PubMed ID: 16142439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth inhibition and demethylation by a component of natural drug, CDP, in cancer cell lines].
    Luan J; Qin Y; Xu D; Sun ZL; Sun ZF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):834-8. PubMed ID: 16334566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Hseu YC; Chen SC; Chen HC; Liao JW; Yang HL
    Food Chem Toxicol; 2008 Aug; 46(8):2680-8. PubMed ID: 18550246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
    Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
    Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of nordihydroguaiaretic acid and its tetra-acetylated derivative on respiration and growth of adenocarcinoma TA3 and its multiresistant variant TA3MTX-R.
    Plaza C; Pavani M; Faundez M; Maya JD; Morello A; Becker MI; De Ioannes A; Cumsille MA; Ferreira J
    In Vivo; 2008; 22(3):353-61. PubMed ID: 18610748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.
    Lopez RA; Goodman AB; Rhodes M; Blomberg JA; Heller J
    Anticancer Drugs; 2007 Sep; 18(8):933-9. PubMed ID: 17667599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma-derived growth factor promotes the resistance to anti-tumor effects of nordihydroguaiaretic acid in colorectal cancer cells.
    Liao F; Liu M; Lv L; Dong W
    Eur J Pharmacol; 2010 Oct; 645(1-3):55-62. PubMed ID: 20674562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
    Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
    J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.
    McDonald RW; Bunjobpon W; Liu T; Fessler S; Pardo OE; Freer IK; Glaser M; Seckl MJ; Robins DJ
    Anticancer Drug Des; 2001 Dec; 16(6):261-70. PubMed ID: 12375879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.